This is why Philip Morris International (PMI) has spent years disrupting its core cigarette business by developing, assessing and marketing non-combustible alternatives to cigarettes. And we will continue to do so.
At PMI Science, we are working to expand the body of scientific evidence related to our smoke-free products. Our aim is to assess and demonstrate the harm reduction potential of these alternatives to cigarettes. Already, we have demonstrated that our tobacco heating system (THS) significantly reduces the formation of and exposure to harmful chemicals compared to cigarettes.
Moving forward, and building on the past decade of experience, capabilities, and scientific work, we have started to execute a significant program of biomarker, clinical outcome and real-world evidence studies to demonstrate individual clinical and public health benefit of our smoke-free products. Already, we have demonstrated that switching to THS can have a positive impact on smokers’ health. And we’ve also seen initial indicators of positive impacts at the population level in some markets.
As we did in the past, our results will be published on PMIScience.com. This website was built to summarize our scientific work and as a way to share our research that is the foundation of our smoke-free products in addition to publications in peer-reviewed journals. PMIScience.com also showcases our expertise spanning many fields of research: basic science, biology, toxicology, inhalation delivery science and technology, regulatory, quality, and clinical science.
I feel privileged to lead this team of exceptional scientists. We keep the interests and welfare of the people for whom we have developed these products — adults who currently smoke — in the forefront and are doing science with the highest level of quality and integrity. I call on the scientific and academic community and policy makers to look at the scientific work going on here at PMI with an unbiased eye and open mind. Let us all work together for the larger public health good.